New generics save patients billions per year, according to FDA report
Generic approvals saved patients a whopping $10.7 billion in 2020 despite challenges posed by the pandemic, according to a new FDA report. And while there …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
